Financials Ahold Delhaize N.V.

Equities

Market Closed - Euronext Amsterdam Other stock markets 11:35:03 2024-11-29 am EST			5-day change	1st Jan Change
32.65 ^EUR	-0.09%		-0.55%	+25.50%

Nov. 28	AHOLD DELHAIZE : JP Morgan maintains a Sell rating	ZD
Nov. 19	AHOLD DELHAIZE : Receives a Sell rating from JP Morgan	ZD

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	66,260	74,736	75,601	86,984	88,649	89,296	92,468	95,177
Change	-	12.79%	1.16%	15.06%	1.91%	0.73%	3.55%	2.93%
EBITDA ¹	5,510	6,435	6,335	7,161	7,066	7,009	7,262	7,581
Change	-	16.79%	-1.55%	13.04%	-1.33%	-0.8%	3.6%	4.4%
EBIT ¹	2,700	3,594	3,331	3,728	3,604	3,596	3,691	3,864
Change	-	33.11%	-7.32%	11.92%	-3.33%	-0.23%	2.65%	4.68%
Interest Paid ¹	-528	-485	-518	-552	-546	-601.8	-671.6	-632.9
Earnings before Tax (EBT) ¹	2,134	1,706	2,803	3,216	2,300	2,713	2,982	3,276
Change	-	-20.06%	64.3%	14.73%	-28.48%	17.95%	9.93%	9.86%
Net income ¹	1,766	1,397	2,246	2,546	1,874	2,114	2,418	2,586
Change	-	-20.89%	60.77%	13.36%	-26.39%	12.83%	14.37%	6.95%
Announcement Date	2/12/20	2/17/21	2/16/22	2/15/23	2/14/24	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4
Net sales ¹	17,378	18,208	19,103	17,826	19,600	18,264	18,645	18,545	20,148	19,774	21,445	22,407	23,359	21,624	22,068	21,934	23,023	21,728	22,349	22,003	23,019
Change	-	4.78%	4.92%	-6.68%	9.95%	-6.82%	2.09%	-0.54%	8.64%	-1.86%	8.45%	4.49%	4.25%	-7.43%	2.05%	-0.61%	4.96%	-5.62%	2.86%	-1.55%	4.62%
EBITDA ¹	1,476	1,666	1,725	-	1,529	1,569	1,562	1,568	1,635	1,636	1,728	1,886	-	1,736	1,764	1,706	1,861	1,721	1,811	1,710	1,802
Change	-	12.87%	3.54%	-100%	-	2.62%	-0.45%	0.38%	4.27%	0.06%	5.62%	9.14%	-100%	-	1.61%	-3.29%	9.09%	-7.52%	5.23%	-5.58%	5.38%
EBIT ¹	749	961	1,009	813	811	849	832	812	838	829	880	993	1,026	864	904	839	996	861	933	855	960.6
Change	-	28.3%	4.99%	-19.43%	-0.25%	4.69%	-2%	-2.4%	3.2%	-1.07%	6.15%	12.84%	3.32%	-15.79%	4.63%	-7.19%	18.71%	-13.55%	8.36%	-8.36%	12.35%
Charge d'intérêts	-132	-142	-108	-124	-	-139	-123	-127	-129	-137	-145	-144	-	-161	-152	-146	-128	-144	-141	-138	-
Earnings before Tax (EBT)	617	822	895	-	-	-	-	-	-	-	-	-	-	-	-	-	547	659	649	-	-
Change	-	33.23%	8.88%	-100%	-	-	-	-	-	-	-	-	-	-	-	-	-	20.48%	-1.52%	-100%	-
Net income ¹	544	645	693	68	-9	-	540	522	634	546	603	589	809	561	468	394	451	513	499	372	628.4
Change	-	18.57%	7.44%	-90.19%	-	-100%	-	-3.33%	21.46%	-13.88%	10.44%	-2.32%	37.35%	-30.66%	-16.58%	-15.81%	14.47%	13.75%	-2.73%	-25.45%	68.93%
Announcement Date	2/12/20	5/7/20	8/5/20	11/4/20	2/17/21	5/12/21	8/11/21	11/10/21	2/16/22	5/11/22	8/10/22	11/9/22	2/15/23	5/10/23	8/9/23	11/8/23	2/14/24	5/8/24	8/7/24	11/6/24	-

¹EUR in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	11,581	11,434	13,946	14,416	14,267	15,108	15,245	14,889
Change	-	-1.27%	21.97%	3.37%	-1.03%	5.89%	0.91%	-2.34%
Announcement Date	2/12/20	2/17/21	2/16/22	2/15/23	2/14/24	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
CAPEX ¹	2,218	2,659	2,371	2,490	2,434	2,418	2,636	2,791
Change	-	19.88%	-10.83%	5.02%	-2.25%	-0.67%	9.04%	5.89%
Free Cash Flow (FCF) ¹	1,843	2,199	1,618	2,188	2,425	2,217	2,084	2,322
Change	-	19.32%	-26.42%	35.23%	10.83%	-8.59%	-6.01%	11.42%
Announcement Date	2/12/20	2/17/21	2/16/22	2/15/23	2/14/24	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Profitability
EBITDA Margin (%)	8.32%	8.61%	8.38%	8.23%	7.97%	7.85%	7.85%	7.97%
EBIT Margin (%)	4.07%	4.81%	4.41%	4.29%	4.07%	4.03%	3.99%	4.06%
EBT Margin (%)	3.22%	2.28%	3.71%	3.7%	2.59%	3.04%	3.23%	3.44%
Net margin (%)	2.67%	1.87%	2.97%	2.93%	2.11%	2.37%	2.62%	2.72%
FCF margin (%)	2.78%	2.94%	2.14%	2.52%	2.74%	2.48%	2.25%	2.44%
FCF / Net Income (%)	104.36%	157.41%	72.04%	85.94%	129.4%	104.84%	86.16%	89.76%
Profitability
ROA	4.64%	5.91%	5.24%	5.4%	3.89%	4.92%	4.72%	4.85%
ROE	13.35%	18.31%	17.3%	17.48%	16.25%	15.98%	16.05%	16.23%
Financial Health
Leverage (Debt/EBITDA)	2.1x	1.78x	2.2x	2.01x	2.02x	2.16x	2.1x	1.96x
Debt / Free cash flow	6.28x	5.2x	8.62x	6.59x	5.88x	6.82x	7.32x	6.41x
Capital Intensity
CAPEX / Current Assets (%)	3.35%	3.56%	3.14%	2.86%	2.75%	2.71%	2.85%	2.93%
CAPEX / EBITDA (%)	40.25%	41.32%	37.43%	34.77%	34.45%	34.49%	36.3%	36.82%
CAPEX / FCF (%)	120.35%	120.92%	146.54%	113.8%	100.37%	109.06%	126.51%	120.23%
Items per share
Cash flow per share ¹	4.9	5.917	5.288	6.104	6.694	6.023	6.792	7.159
Change	-	20.75%	-10.63%	15.42%	9.66%	-10.01%	12.76%	5.41%
Dividend per Share ¹	0.76	0.9	0.95	1.05	1.1	1.142	1.194	1.292
Change	-	18.42%	5.56%	10.53%	4.76%	3.84%	4.53%	8.19%
Book Value Per Share ¹	12.94	11.65	13.35	15.48	15.6	16.37	17.4	18.98
Change	-	-9.99%	14.55%	16%	0.74%	4.98%	6.28%	9.06%
EPS ¹	1.59	1.3	2.17	2.54	1.94	2.242	2.677	2.947
Change	-	-18.24%	66.92%	17.05%	-23.62%	15.58%	19.41%	10.06%
Nbr of stocks (in thousands)	1,087,956	1,047,005	1,014,615	977,353	960,753	921,239	921,239	921,239
Announcement Date	2/12/20	2/17/21	2/16/22	2/15/23	2/14/24	-	-	-